Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.
Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Kälebo P, Christiansen AV, Hantel S, Hettiarachchi R, Schnee J, Büller HR; RE-MODEL Study Group. Eriksson BI, et al. Among authors: christiansen av. J Thromb Haemost. 2007 Nov;5(11):2178-85. doi: 10.1111/j.1538-7836.2007.02748.x. J Thromb Haemost. 2007. PMID: 17764540 Free article. Clinical Trial.
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.
Schulman S, Kakkar AK, Goldhaber SZ, Schellong S, Eriksson H, Mismetti P, Christiansen AV, Friedman J, Le Maulf F, Peter N, Kearon C; RE-COVER II Trial Investigators. Schulman S, et al. Among authors: christiansen av. Circulation. 2014 Feb 18;129(7):764-72. doi: 10.1161/CIRCULATIONAHA.113.004450. Epub 2013 Dec 16. Circulation. 2014. PMID: 24344086 Free article. Clinical Trial.
Empagliflozin as add-on to metformin in people with Type 2 diabetes.
Merker L, Häring HU, Christiansen AV, Roux F, Salsali A, Kim G, Meinicke T, Woerle HJ, Broedl UC; EMPA-REG EXTEND MET investigators. Merker L, et al. Among authors: christiansen av. Diabet Med. 2015 Dec;32(12):1555-67. doi: 10.1111/dme.12814. Epub 2015 Jul 14. Diabet Med. 2015. PMID: 26031566 Clinical Trial.
Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetes.
Haering HU, Merker L, Christiansen AV, Roux F, Salsali A, Kim G, Meinicke T, Woerle HJ, Broedl UC; EMPA-REG EXTEND™ METSU investigators. Haering HU, et al. Among authors: christiansen av. Diabetes Res Clin Pract. 2015 Oct;110(1):82-90. doi: 10.1016/j.diabres.2015.05.044. Epub 2015 May 29. Diabetes Res Clin Pract. 2015. PMID: 26324220 Clinical Trial.
Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial.
Roden M, Merker L, Christiansen AV, Roux F, Salsali A, Kim G, Stella P, Woerle HJ, Broedl UC; EMPA-REG EXTEND™ MONO investigators. Roden M, et al. Among authors: christiansen av. Cardiovasc Diabetol. 2015 Dec 23;14:154. doi: 10.1186/s12933-015-0314-0. Cardiovasc Diabetol. 2015. PMID: 26701110 Free PMC article. Clinical Trial.
Reply to Williams et al.: Fair and Safe Eligibility Criteria for Women's Sport.
Tucker R, Hilton EN, McGawley K, Pollock N, Millet GP, Sandbakk Ø, Howatson G, Brown GA, Carlson LA, Chen MA, Heron N, Kirk C, Murphy MH, Pringle J, Richardson A, Santos-Concejero J, Christiansen AV, Jones C, Alonso JM, Robinson R, Jones N, Wilson M, Parker MG, Chintoh A, Hunter S, Senefeld JW, O'Connor MI, Joyner M, Carneiro EM, Devine C, Pike J, Lundberg TR. Tucker R, et al. Among authors: christiansen av. Scand J Med Sci Sports. 2024 Nov;34(11):e14754. doi: 10.1111/sms.14754. Scand J Med Sci Sports. 2024. PMID: 39492644 No abstract available.
Fair and Safe Eligibility Criteria for Women's Sport.
Tucker R, Hilton EN, McGawley K, Pollock N, Millet GP, Sandbakk Ø, Howatson G, Brown GA, Carlson LA, Chen MA, Heron N, Kirk C, Murphy MH, Pringle J, Richardson A, Santos-Concejero J, Christiansen AV, Jones C, Alonso JM, Robinson R, Jones N, Wilson M, Parker MG, Chintoh A, Hunter S, Senefeld JW, O'Connor MI, Joyner M, Carneiro EM, Devine C, Pike J, Lundberg TR. Tucker R, et al. Among authors: christiansen av. Scand J Med Sci Sports. 2024 Aug;34(8):e14715. doi: 10.1111/sms.14715. Scand J Med Sci Sports. 2024. PMID: 39169560 No abstract available.
The International Olympic Committee framework on fairness, inclusion and nondiscrimination on the basis of gender identity and sex variations does not protect fairness for female athletes.
Lundberg TR, Tucker R, McGawley K, Williams AG, Millet GP, Sandbakk Ø, Howatson G, Brown GA, Carlson LA, Chantler S, Chen MA, Heffernan SM, Heron N, Kirk C, Murphy MH, Pollock N, Pringle J, Richardson A, Santos-Concejero J, Stebbings GK, Christiansen AV, Phillips SM, Devine C, Jones C, Pike J, Hilton EN. Lundberg TR, et al. Among authors: christiansen av. Scand J Med Sci Sports. 2024 Mar;34(3):e14581. doi: 10.1111/sms.14581. Scand J Med Sci Sports. 2024. PMID: 38511417 Free article.
23 results